Some comments breaking
- Preliminary evidence suggests latest coronavirus variant carries higher risk of reinfection than other variants of concern
- It may have a 'growth' advantage
But the main issues remains - is the vaccine effective against it?
But the main issues remains - is the vaccine effective against it?
Most Popular
Sponsored
Oil dips 1% on trade deal skepticism; Brent $65.70, WTI $61.26. Iraq exports steady despite fire.
Global public debt nears 100% of GDP by 2029; US debt-to-GDP to hit 143.4% by 2030, a systemic risk.
Trade talks surge! S&P +0.9%, Dow & Nasdaq gain on US-China deal hopes. Tariffs off table, soybeans to flow.
US futures surge on China trade optimism & Fed rate cut hopes. RNA +40% on NVS buyout; Argentine stocks soar 30%+ on election wins.
Dalio warns US economy's top 1% drives growth, leaving 60% behind. AI amplifies inequality, risking stability.
Saudi Arabia's non-oil sector hits 56% of $1.3T economy; Barclays returns after 11 yrs. Africa's GDP to grow 10x.
Dow futures jump 200 pts on China trade truce hopes; gold dips. Traders eye global rally.
Sponsored
Must Read